Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4576291 | 0.75 | CES2 (0.31) | CES2 | |
| SCHEMBL632464 | 0.72 | CA2 (0.37) | CES2 | |
| SCHEMBL10804295 | 0.72 | CES2 (0.35) | CES2 | |
| SCHEMBL5582102 | 0.72 | CES2 (0.35) | CES2 | |
| SCHEMBL5075464 | 0.71 | THRB (0.31) | — | |
| SCHEMBL10802070 | 0.70 | CES2 (0.34) | CES2 | |
| SCHEMBL10798446 | 0.70 | CES2 (0.34) | CES2 | |
| SCHEMBL10803227 | 0.70 | CES2 (0.34) | CES2 | |
| SCHEMBL7118937 | 0.68 | — | — | |
| SCHEMBL15271631 | 0.67 | THRB (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1587784-A4 | BISAMINOPHENYL-BASED CURATIVES AND AMIDINE-BASED CURATIVES AND CURE ACCELERATORS FOR PERFLUOROELASTOMERIC COMPOSITIONS | GREENE TWEED INC (US) | 2008-10-29 | — | — | EP | disclosed |
| EP-1587784-A2 | BISAMINOPHENYL-BASED CURATIVES AND AMIDINE-BASED CURATIVES AND CURE ACCELERATORS FOR PERFLUOROELASTOMERIC COMPOSITIONS | GREENE, TWEED OF DELAWARE, INC. (US) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004069900-A2 | BISAMINOPHENYL-BASED CURATIVES AND AMIDINE-BASED CURATIVES AND CURE ACCELERATORS FOR PERFLUOROELASTOMERIC COMPOSITIONS | GREENE, TWEED OF DELAWARE, INC. (US) | 2004-08-19 | — | — | WO | disclosed |